Head to head

LightPod Neo vs Excel HR (2026)

Compare purchase costs, running costs and the evidence behind each device.

Read the comparison overview

Purchase cost: The catalog lists $95k–$135k for Excel HR. No new-price range is on file for LightPod Neo. Check the source notes and request current quotes.
Practice fit: LightPod Neo: nd:yag laser (microsecond). Excel HR: dual-wavelength laser. Check each model’s US regulatory status and labeled indications for your intended use.

Device A

Nd:YAG laser (microsecond)

View full device profile →

Device B

Dual-wavelength laser

View full device profile →

Price comparison

Price comparison: Aerolase LightPod Neo vs Cutera Excel HR
Attribute	Aerolase LightPod Neo	Cutera Excel HR
New price range	Not published	$95k–$135kSource not documented
Used asking range	$15k–$30kSource not documented	$40k–$70kSource not documented
Payback calculator	View ROI calculator	View ROI calculator
Next step	Explore this model’s specs and owner reviews. For new-equipment inquiries, browse current models. Browse current models

New price range

Aerolase LightPod Neo: Not published
Cutera Excel HR: $95k–$135kSource not documented

Used asking range

Aerolase LightPod Neo: $15k–$30kSource not documented
Cutera Excel HR: $40k–$70kSource not documented

Payback calculator

Aerolase LightPod Neo: View ROI calculator
Cutera Excel HR: View ROI calculator

Next step

Aerolase LightPod Neo

Explore this model’s specs and owner reviews. For new-equipment inquiries, browse current models.

Browse current models

Cutera Excel HR

Consumable economics

Consumable economics: Aerolase LightPod Neo vs Cutera Excel HR
Attribute	Aerolase LightPod Neo	Cutera Excel HR
Consumable cost / lock-in	—	Supply pricing is not documented with a dated source yet. Request an itemized supply quote.
Service cost	Not published	Not published

Consumable cost / lock-in

Aerolase LightPod Neo: —
Cutera Excel HR: Supply pricing is not documented with a dated source yet. Request an itemized supply quote.

Service cost

Aerolase LightPod Neo: Not published
Cutera Excel HR: Not published

FDA clearance

FDA clearance: Aerolase LightPod Neo vs Cutera Excel HR
Attribute	Aerolase LightPod Neo	Cutera Excel HR
FDA status & indication	FDA ClearedK120235 Read FDA indication wording “The Aerolase Nd:YAG Laser is intended for use in the medical specialties of general and plastic surgery, dermatology, endoscopic/laparoscopic general surgery, gastroenterology, gynecology, otolaryngology (ENT), neurosurgery, oculoplastics, orthopedics, pulmonary/thoracic surgery, podiatry, and urology for surgical and aesthetic applications. Dermatology: The Aerolase Nd:YAG Laser is intended for the coagulation and hemostasis of benign vascular lesions such as, but not limited to, port wine stains, hemangiomas, warts, telangiectasia, rosacea, venus lake, leg veins, spider veins and poikiloderma of civatte: and treatment of benign cutaneous lesions, such as warts, scars, striae, debridement of decubitus ulcer, treatment of keloids, and psoriasis. The laser is also intended for the treatment of benign pigmented lesions such as, but not limited to, Ic(r;,73,J 7 4 lentigos (age spots), solar lentigos (sun spots), cafe au lait macules, seborrheic keratoses. nevi, chloasma, verrucae, skin tags, keratoses, tattoos (significant reduction in the intensity of black and/or blue/black tattoos) and plaques. Additionally, the Aerolase Nd:YAG Laser is indicated for pigmented lesions to reduce lesion size, for patients with lesions that would potentially benefit from aggressive treatment, and for patients with lesions that have not responded to other laser treatments. The Aerolase Nd:YAG Laser is also indicated for the treatment of wrinkles, such as, but not limited to, periocular and perioral wrinkles. The Aerolase Nd:YAG Laser is also indicated for the reduction of red pigmentation in hypertrophic and keloid scars where vascularity is an integral part of the scar. The Aerolase Nd:YAG Laser is also indicated for treatment of mild to moderate inflammatory acne vulgaris. The Aerolase Nd:YAG Laser is also indicated for the removal of unwanted hair, for stable long-term, or permanent, hair reduction through selective targeting of melanin in hair follicles, and for the treatment for pseudofolliculitis barbae (PFB). Permanent hair reduction is defined as the long-term, stable reduction in the number of hairs regrowing when measured at 6, 9, and 12 months after the completion of a treatment regime. The Aerolase Nd:YAG Laser is indicated for use on all skin types (Fitzpatrick I-VI), including tanned skin.”	FDA ClearedK132185 Read FDA indication wording “Family of CoolGlide Aesthetic Lasers The Cutera Family of CoolGlide Aesthetic Lasers is intended for use in surgical and aesthetic applications in the medical specialties of dermatology and general and plastic surgery. 755 nm: The Family of CoolGlide Aesthetic Lasers is indicated for temporary and permanent hair reduction on all skin types (Fitzpatrick I-VI), including tanned skin. Permanent hair reduction is defined as tong-term, stable reduction in hair counts observed atS6, 9,and 12 months after the end of a treatment regime. The Family of CoolGlide Aesthetic Lasers is also indicated for: o treatment of benign pigmented lesions o treatment of wrinkles ol photocoagulation of dermatological vascular lesions such as, but not limited to, port wine stains, hemangiomas and telangiectasias 1064 nm: Dermatology: The Family of CoolGlide Aesthetic Lasers is intended for the coagulation and hemostasis of benign vascular lesions such as, but not limited to, port wine stains, hemangiomas, warts, telangiectasias, rossosa, venus lake, leg veins, spider veins and poikiloderma of civatte; and treatment of benign cutaneous lesions such as, but not limited to, warts, scars, striae and psoriasis. The lasers are also intended for the treatment of benign pigmented lesions such as, but not limited to, lentigos (age soots), solar lentigos (sun spots), caf4 au lait macules, seborrheic keratoses, nevi, chloasma, verrucae, skin tags, keratoses, tattoos (significant reduction in the intensity of black and/or blue/black tattoos) and plaques. Additionally, the lasers are indicated for pigmented lesions to reduce lesion size, for patients with lesions that would potentially benefit from aggressive treatment, and for patients with lesions that have not responded to other laser treatments.”

FDA status & indication

Aerolase LightPod Neo: FDA ClearedK120235
Read FDA indication wording
“The Aerolase Nd:YAG Laser is intended for use in the medical specialties of general and plastic surgery, dermatology, endoscopic/laparoscopic general surgery, gastroenterology, gynecology, otolaryngology (ENT), neurosurgery, oculoplastics, orthopedics, pulmonary/thoracic surgery, podiatry, and urology for surgical and aesthetic applications. Dermatology: The Aerolase Nd:YAG Laser is intended for the coagulation and hemostasis of benign vascular lesions such as, but not limited to, port wine stains, hemangiomas, warts, telangiectasia, rosacea, venus lake, leg veins, spider veins and poikiloderma of civatte: and treatment of benign cutaneous lesions, such as warts, scars, striae, debridement of decubitus ulcer, treatment of keloids, and psoriasis. The laser is also intended for the treatment of benign pigmented lesions such as, but not limited to, Ic(r;,73,J 7 4 lentigos (age spots), solar lentigos (sun spots), cafe au lait macules, seborrheic keratoses. nevi, chloasma, verrucae, skin tags, keratoses, tattoos (significant reduction in the intensity of black and/or blue/black tattoos) and plaques. Additionally, the Aerolase Nd:YAG Laser is indicated for pigmented lesions to reduce lesion size, for patients with lesions that would potentially benefit from aggressive treatment, and for patients with lesions that have not responded to other laser treatments. The Aerolase Nd:YAG Laser is also indicated for the treatment of wrinkles, such as, but not limited to, periocular and perioral wrinkles. The Aerolase Nd:YAG Laser is also indicated for the reduction of red pigmentation in hypertrophic and keloid scars where vascularity is an integral part of the scar. The Aerolase Nd:YAG Laser is also indicated for treatment of mild to moderate inflammatory acne vulgaris. The Aerolase Nd:YAG Laser is also indicated for the removal of unwanted hair, for stable long-term, or permanent, hair reduction through selective targeting of melanin in hair follicles, and for the treatment for pseudofolliculitis barbae (PFB). Permanent hair reduction is defined as the long-term, stable reduction in the number of hairs regrowing when measured at 6, 9, and 12 months after the completion of a treatment regime. The Aerolase Nd:YAG Laser is indicated for use on all skin types (Fitzpatrick I-VI), including tanned skin.”
Cutera Excel HR: FDA ClearedK132185
Read FDA indication wording
“Family of CoolGlide Aesthetic Lasers The Cutera Family of CoolGlide Aesthetic Lasers is intended for use in surgical and aesthetic applications in the medical specialties of dermatology and general and plastic surgery. 755 nm: The Family of CoolGlide Aesthetic Lasers is indicated for temporary and permanent hair reduction on all skin types (Fitzpatrick I-VI), including tanned skin. Permanent hair reduction is defined as tong-term, stable reduction in hair counts observed atS6, 9,and 12 months after the end of a treatment regime. The Family of CoolGlide Aesthetic Lasers is also indicated for: o treatment of benign pigmented lesions o treatment of wrinkles ol photocoagulation of dermatological vascular lesions such as, but not limited to, port wine stains, hemangiomas and telangiectasias 1064 nm: Dermatology: The Family of CoolGlide Aesthetic Lasers is intended for the coagulation and hemostasis of benign vascular lesions such as, but not limited to, port wine stains, hemangiomas, warts, telangiectasias, rossosa, venus lake, leg veins, spider veins and poikiloderma of civatte; and treatment of benign cutaneous lesions such as, but not limited to, warts, scars, striae and psoriasis. The lasers are also intended for the treatment of benign pigmented lesions such as, but not limited to, lentigos (age soots), solar lentigos (sun spots), caf4 au lait macules, seborrheic keratoses, nevi, chloasma, verrucae, skin tags, keratoses, tattoos (significant reduction in the intensity of black and/or blue/black tattoos) and plaques. Additionally, the lasers are indicated for pigmented lesions to reduce lesion size, for patients with lesions that would potentially benefit from aggressive treatment, and for patients with lesions that have not responded to other laser treatments.”

Which chains run each

Which chains run each: Aerolase LightPod Neo vs Cutera Excel HR
Attribute	Aerolase LightPod Neo	Cutera Excel HR
Chain adoption	0 recorded pairings	0 recorded pairings
Chains using it	—	—
Approved reviews	0	0

Chain adoption

Aerolase LightPod Neo: 0 recorded pairings
Cutera Excel HR: 0 recorded pairings

Chains using it

Aerolase LightPod Neo: —
Cutera Excel HR: —

Approved reviews

Aerolase LightPod Neo: 0
Cutera Excel HR: 0

Specs and platform

Specs and platform: Aerolase LightPod Neo vs Cutera Excel HR
Attribute	Aerolase LightPod Neo	Cutera Excel HR
Manufacturer	Aerolase	Cutera
Built by (OEM)	Aerolase Corp.	Cutera Inc.
Category	Nd:YAG laser (microsecond)	Dual-wavelength laser
Technology	1064nm 650-microsecond Nd:YAG (Nd:YAG)	755nm alex + 1064nm Nd:YAG (Nd:YAG)
Launch year	2010	2015
Status	Discontinued	Current
Manufacturer source record	No linked source on file.	No linked source on file.

Manufacturer

Aerolase LightPod Neo: Aerolase
Cutera Excel HR: Cutera

Built by (OEM)

Aerolase LightPod Neo: Aerolase Corp.
Cutera Excel HR: Cutera Inc.

Current alternatives

Current catalog models in related categories. Confirm availability and configuration with the supplier.

Lumenis Splendor X

Dual-wavelength laser

New: $130k–$165k

Lutronic Clarity II

Dual-wavelength laser

New: $100k–$140k

Quanta System Thunder (MT)

Dual-wavelength laser

New: $110k–$150k

Quanta System Duetto MT / MT Evo

Dual-wavelength laser

New: $80k–$120k

Get a free recommendation Browse by goal

Device and company names are trademarks of their respective owners. The Aesthetic Index is not affiliated with or endorsed by any manufacturer, distributor or lender named here, except as disclosed. Price figures are references, not current offers. Check each device’s source notes. Not medical, legal or regulatory advice.